123 related articles for article (PubMed ID: 38117565)
41. The role of oncogenic human papillomavirus determination for diagnosis of high-grade anal intraepithelial neoplasia in HIV-infected MSM.
Burgos J; Hernández-Losa J; Landolfi S; Guelar A; Dinares M; Villar J; Navarro J; Ribera E; Falcó V; Curran A
AIDS; 2017 Oct; 31(16):2227-2233. PubMed ID: 28723712
[TBL] [Abstract][Full Text] [Related]
42. Antiretroviral therapy as a factor protective against anal dysplasia in HIV-infected males who have sex with males.
Hidalgo-Tenorio C; Rivero-Rodriguez M; Gil-Anguita C; Lopez De Hierro M; Palma P; Ramírez-Taboada J; Esquivias J; López-Ruz MA; Javier-Martínez R; Pasquau-Liaño J
PLoS One; 2014; 9(3):e92376. PubMed ID: 24676139
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening.
Rijkaart DC; Berkhof J; van Kemenade FJ; Coupe VM; Hesselink AT; Rozendaal L; Heideman DA; Verheijen RH; Bulk S; Verweij WM; Snijders PJ; Meijer CJ
Int J Cancer; 2012 Feb; 130(3):602-10. PubMed ID: 21400507
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis.
Berkhof J; de Bruijne MC; Zielinski GD; Bulkmans NW; Rozendaal L; Snijders PJ; Verheijen RH; Meijer CJ
Int J Cancer; 2006 Apr; 118(7):1759-68. PubMed ID: 16217759
[TBL] [Abstract][Full Text] [Related]
45. The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer.
Barrett JE; Sundström K; Jones A; Evans I; Wang J; Herzog C; Dillner J; Widschwendter M
Genome Med; 2022 Oct; 14(1):116. PubMed ID: 36258199
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
[TBL] [Abstract][Full Text] [Related]
47. Comparison of two sample collection devices for anal cytology in HIV-positive men who have sex with men: Cytology brush and Dacron swab.
Silva-Klug AC; Saumoy M; Baixeras N; Trenti L; Catala I; Vidal A; Torres M; Alemany L; Videla S; De San Jose S; Podzamczer D
Cytopathology; 2021 Sep; 32(5):646-653. PubMed ID: 34033168
[TBL] [Abstract][Full Text] [Related]
48. Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting.
Kotaniemi-Talonen L; Nieminen P; Anttila A; Hakama M
Br J Cancer; 2005 Oct; 93(8):862-7. PubMed ID: 16189520
[TBL] [Abstract][Full Text] [Related]
49. The influence of home versus clinic anal human papillomavirus sampling on high-resolution anoscopy uptake in the Prevent Anal Cancer Self-Swab Study.
Nitkowski J; Ridolfi TJ; Lundeen SJ; Giuliano AR; Chiao EY; Fernandez ME; Schick V; Smith JS; Brzezinski B; Nyitray AG
Sex Health; 2024 Apr; 21():. PubMed ID: 38683939
[TBL] [Abstract][Full Text] [Related]
50. Cytology-based screening for anal intraepithelial neoplasia in women with a history of cervical intraepithelial neoplasia or cancer.
Wohlmuth C; Ghorab Z; Shier M; Tinmouth J; Salit IE; Covens A; Zhang L; Vicus D
Cancer Cytopathol; 2021 Feb; 129(2):140-147. PubMed ID: 33002327
[TBL] [Abstract][Full Text] [Related]
51. International Anal Neoplasia Society's consensus guidelines for anal cancer screening.
Stier EA; Clarke MA; Deshmukh AA; Wentzensen N; Liu Y; Poynten IM; Cavallari EN; Fink V; Barroso LF; Clifford GM; Cuming T; Goldstone SE; Hillman RJ; Rosa-Cunha I; La Rosa L; Palefsky JM; Plotzker R; Roberts JM; Jay N
Int J Cancer; 2024 May; 154(10):1694-1702. PubMed ID: 38297406
[TBL] [Abstract][Full Text] [Related]
52. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
[TBL] [Abstract][Full Text] [Related]
53. Risk stratification for cervical neoplasia using extended high-risk HPV genotyping in women with ASC-US cytology: A large retrospective study from China.
Tao X; Austin RM; Yu T; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
Cancer Cytopathol; 2022 Apr; 130(4):248-258. PubMed ID: 34874615
[TBL] [Abstract][Full Text] [Related]
54. Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki-67 dual-stained cytology-Retrospective insights from ATHENA.
Stoler MH; Baker E; Boyle S; Aslam S; Ridder R; Huh WK; Wright TC
Int J Cancer; 2020 May; 146(9):2599-2607. PubMed ID: 31490545
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of high-risk human papillomavirus testing and anal cytology to detect high-grade anal intraepithelial neoplasia.
Swanson AA; Hartley C; Long ME; Chantigian PDM; Casey PM; Jenkins SM; Boerger AC; Binnicker MJ; Henry MR
J Am Soc Cytopathol; 2021; 10(4):406-413. PubMed ID: 33896747
[TBL] [Abstract][Full Text] [Related]
56. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
[TBL] [Abstract][Full Text] [Related]
57. Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM.
Wentzensen N; Follansbee S; Borgonovo S; Tokugawa D; Schwartz L; Lorey TS; Sahasrabuddhe VV; Lamere B; Gage JC; Fetterman B; Darragh TM; Castle PE
AIDS; 2012 Nov; 26(17):2185-92. PubMed ID: 23018436
[TBL] [Abstract][Full Text] [Related]
58. Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men.
Chin-Hong PV; Berry JM; Cheng SC; Catania JA; Da Costa M; Darragh TM; Fishman F; Jay N; Pollack LM; Palefsky JM
Ann Intern Med; 2008 Sep; 149(5):300-6. PubMed ID: 18765699
[TBL] [Abstract][Full Text] [Related]
59. The role of polymerase chain reaction of high-risk human papilloma virus in the screening of high-grade squamous intraepithelial lesions in the anal mucosa of human immunodeficiency virus-positive males having sex with males.
Hidalgo-Tenorio C; Rivero-Rodriguez M; Gil-Anguita C; Esquivias J; López-Castro R; Ramírez-Taboada J; de Hierro ML; López-Ruiz MA; Martínez RJ; Llaño JP
PLoS One; 2015; 10(4):e0123590. PubMed ID: 25849412
[TBL] [Abstract][Full Text] [Related]
60. Cost-effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-testing with hrHPV Genotyping for Cervical Cancer Screening.
Harper DM; Anderson RJ; Baker E; Yu TM
Cancer Prev Res (Phila); 2023 Jul; 16(7):393-404. PubMed ID: 37210751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
